• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges 100 Points; Ciena Posts Upbeat Earnings

    12/7/23 2:26:12 PM ET
    $BNED
    $CIEN
    $CYN
    $PHIO
    Other Specialty Stores
    Consumer Discretionary
    Telecommunications Equipment
    Utilities
    Get the next $BNED alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Thursday.

    The Dow traded up 0.28% to 36,155 while the NASDAQ rose 1.41% to 14,346.47. The S&P 500 also rose, gaining, 0.86% to 4,588.61.

    Check This Out: Top 5 Tech Stocks You May Want To Dump In December

     

    Leading and Lagging Sectors

     

    Communication services shares rose by 3.9% on Thursday.

    In trading on Thursday, health care shares fell by 0.8%.

     

    Top Headline

     

    Ciena Corp (NYSE:CIEN) reported better-than-expected fourth-quarter earnings.

    Ciena reported a fourth-quarter FY23 revenue growth of 16% year-on-year to $1.129 billion, beating the consensus estimate of $1.095 billion. The company reported an adjusted EPS of 75cents, beating the consensus of 69 cents.

     

    Equities Trading UP

     

    Save Foods, Inc. (NASDAQ:SVFD) shares shot up 93% to $4.1601 after the company highlighted it's targeting the US carbon credit market following the acquisition of majority ownership in the newly-formed Nitrousink Ltd.

    Shares of Cyngn Inc. (NASDAQ:CYN) got a boost, shooting 88% to $0.4599 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.

    Barnes & Noble Education, Inc. (NYSE:BNED) shares were also up, gaining 26% to $1.32 following upbeat quarterly earnings.

     

    Equities Trading DOWN

     

    Troika Media Group, Inc. (NASDAQ:TRKA) shares dropped 64% to $0.6792 after the company announced it filed for Chapter 11.

    Shares of ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) were down 35% to $1.4001 after the company priced its $5 million public offering.

    Phio Pharmaceuticals Corp. (NASDAQ:PHIO) was down, falling 41% to $0.9436 as the company announced exercise of warrants for $2.8 million gross proceeds.

    Also Check This Out: Bitcoin, Ethereum Fall Following Jobless Claims Data; BitTorrent Becomes Top Loser

     

    Commodities

     

    In commodity news, oil traded down 0.2% to $69.26 while gold traded down 0.5% at $2,037.90.

    Silver traded down 1.1% to $23.955 on Thursday while copper rose 1.3% to $3.7825.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.27%, London’s FTSE 100 fell 0.02% while Spain’s IBEX 35 Index fell 1.09% The German DAX fell 0.16% French CAC 40 fell 0.10%, while Italy’s FTSE MIB Index fell 0.67%.

    The Eurozone economy shrank by 0.1% in the third quarter versus a revised 0.1% expansion in the prior three-month period. The number of employed persons in the Eurozone increased by 0.2% from the earlier quarter to 168.7 million in the third quarter.

    French trade deficit shrank to €8.6 billion in October versus a revised €8.87 billion in the prior month, while current account deficit increased to €2.9 billion in October from a revised €2.8 billion a month ago. Industrial production in Germany declined 0.4% month-over-month for October. The Halifax House Price Index fell by 1.0% year-over-year during November.

     

    Asia Pacific Markets

     

    Asian markets closed lower on Thursday, with Japan’s Nikkei 225 falling 1.76%, Hong Kong’s Hang Seng Index falling 0.71% and China’s Shanghai Composite Index falling 0.09%. India’s S&P BSE Sensex, meanwhile, fell 0.19%.

    The index of coincident economic indicators in Japan rose to 115.9 in October versus a revised 115.7 in the previous month, while index of leading economic indicators fell to 108.7 in October versus a revised 109.3 a month ago. China's trade surplus widened to $68.39 billion in November from $66.49 billion in the year-ago period.

     

    Economics

     

    U.S. initial jobless claims rose by 1,000 to 220,000 in the week ending Dec. 2, compared to market estimates of 222,000.

    U.S.-based employers announced plans to reduce 45,510 jobs during November.

    The Manheim Used Vehicle Value Index for the U.S. declined 2.1% month-over-month in November versus a 2.3% decline in October.

    U.S. wholesale inventories declined by 0.4% month-over-month in October versus preliminary estimate of a 0.2% decline.

    U.S. natural-gas supplies fell 117 billion cubic feet last week, the EIA said.

    Now Read This: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD

    Get the next $BNED alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNED
    $CIEN
    $CYN
    $PHIO

    CompanyDatePrice TargetRatingAnalyst
    Ciena Corporation
    $CIEN
    3/12/2026$425.00Buy
    TD Cowen
    Ciena Corporation
    $CIEN
    3/6/2026$355.00Neutral → Buy
    BofA Securities
    Ciena Corporation
    $CIEN
    1/20/2026Buy → Neutral
    BofA Securities
    Ciena Corporation
    $CIEN
    12/12/2025$190.00Outperform → Market Perform
    Northland Capital
    Ciena Corporation
    $CIEN
    10/13/2025$185.00Neutral → Outperform
    BNP Paribas Exane
    Ciena Corporation
    $CIEN
    10/10/2025$140.00Underweight → Equal-Weight
    Morgan Stanley
    Ciena Corporation
    $CIEN
    9/26/2025$175.00Neutral → Buy
    Rosenblatt
    Ciena Corporation
    $CIEN
    9/5/2025$113.00Buy → Neutral
    B. Riley Securities
    More analyst ratings

    $BNED
    $CIEN
    $CYN
    $PHIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Ciena with a new price target

    TD Cowen initiated coverage of Ciena with a rating of Buy and set a new price target of $425.00

    3/12/26 8:50:16 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    Ciena upgraded by BofA Securities with a new price target

    BofA Securities upgraded Ciena from Neutral to Buy and set a new price target of $355.00

    3/6/26 8:18:05 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    Ciena downgraded by BofA Securities

    BofA Securities downgraded Ciena from Buy to Neutral

    1/20/26 9:05:04 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $BNED
    $CIEN
    $CYN
    $PHIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    12/29/25 8:10:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,700 worth of shares (5,000 units at $1.14), increasing direct ownership by 2% to 281,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    11/24/25 12:54:10 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CIEN
    $CYN
    $PHIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Barnes & Noble Education to Host Investor Day on June 25, 2026

    FLORHAM PARK, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today announced it will host a virtual Investor Day on Thursday, June 25, 2026, broadcast live from the New York Stock Exchange. During the event, BNED's leadership team will present a comprehensive overview of the Company's strategy, key growth drivers, and financial outlook. The presentation will highlight BNED's focus on improving affordability and outcomes for students, expanding its First Day® programs, and enhancing its omnichannel campus retail model to bett

    4/23/26 8:30:00 AM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

    Live Presentation and Q&A: Wednesday, April 29, 2026 12 PM EDTKing of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities, followed by a live Q&A.Phio's lead clinical candidate, PH-762, is being evaluated as an intratumoral therapy in cutaneous squamous cell carcinoma (cSCC), mela

    4/23/26 7:00:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026

    Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR. Todd Plott, M.D., Chief Medical Officer, Epiphany Dermatology will join Robert Bitterman, Phio Pharmaceuticals and Steven Saltzstein, Force Family OfficeKing of Prussia, Pennsylvania--(Newsfile Corp. - April 13, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will participate in a fireside chat with Steven Saltzstein, CE

    4/13/26 7:00:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CIEN
    $CYN
    $PHIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Smith Gary B

    4 - CIENA CORP (0000936395) (Issuer)

    4/17/26 3:29:02 PM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    SEC Form 4 filed by Rothenstein David M

    4 - CIENA CORP (0000936395) (Issuer)

    4/17/26 3:23:41 PM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    SEC Form 4 filed by Gage Brodie

    4 - CIENA CORP (0000936395) (Issuer)

    4/17/26 3:08:39 PM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $BNED
    $CIEN
    $CYN
    $PHIO
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cyngn Inc.

    SCHEDULE 13G - Cyngn Inc. (0001874097) (Subject)

    4/22/26 9:01:55 AM ET
    $CYN
    EDP Services
    Technology

    Phio Pharmaceuticals Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Phio Pharmaceuticals Corp. (0001533040) (Filer)

    4/8/26 4:15:54 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Phio Pharmaceuticals Corp.

    424B5 - Phio Pharmaceuticals Corp. (0001533040) (Filer)

    4/8/26 4:13:18 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CIEN
    $CYN
    $PHIO
    Financials

    Live finance-specific insights

    View All

    ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

    ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks. Lead indication: Cardiometabolic conditions associated with obesityValue driving milestones: File IND Q4-2026; Phase 1 SAD read-out Q1-2027 Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddress

    3/31/26 5:05:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cyngn Announces Date for 2025 Fourth Quarter and Year-End Financial Results

    MOUNTAIN VIEW, Calif., March 5, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) will announce its 2025 fourth quarter and year-end financial results for the period ended December 31, 2025, on Wednesday, March 25, 2026, after the close of market. The financial results will be available on the Cyngn website under "News & Events" at https://investors.cyngn.com/.  The Company will not host an earnings call.About CyngnCyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges f

    3/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Ciena Announces Reporting Date and Web Broadcast for Fiscal First Quarter 2026 Results

    Ciena® Corporation (NYSE:CIEN), the global leader in high-speed connectivity, expects to announce its fiscal first quarter financial results on Thursday, March 5, 2026 before the open of the financial markets. The press release will be available on Ciena's website at www.ciena.com. In conjunction with the announcement, Ciena will post an additional set of supporting materials to the Quarterly Results page of the Investor Relations section of its website. Ciena's management will then host a live audio web broadcast beginning at 8:30 a.m. Eastern accessible via www.ciena.com. Rebroadcast Information For those listeners unable to participate in the live web broadcast, an archived version

    2/5/26 9:00:00 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $BNED
    $CIEN
    $CYN
    $PHIO
    Leadership Updates

    Live Leadership Updates

    View All

    Barnes & Noble Education Reports Fiscal Third Quarter 2026 Financial Results

    BNC First Day Program Revenue Increases 32.1% Net Income of $6.7 Million and Adjusted EBITDA of $23.6 Million Company to Commence Dividend Program in First Quarter of Fiscal 2027 Virtual Investor Day Scheduled for June 25, 2026 FLORHAM PARK, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today reported financial results for the fiscal third quarter ended January 31, 2026. Virtual Investor Day Barnes & Noble Education has scheduled a virtual investor day for June 25, 2026. Management will provide an overview of the Com

    3/10/26 4:15:00 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CIEN
    $CYN
    $PHIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Barnes & Noble Education Inc

    SC 13G/A - Barnes & Noble Education, Inc. (0001634117) (Subject)

    11/14/24 6:34:18 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ZyVersa Therapeutics Inc.

    SC 13G/A - ZyVersa Therapeutics, Inc. (0001859007) (Subject)

    11/14/24 6:01:27 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cyngn Inc.

    SC 13G/A - Cyngn Inc. (0001874097) (Subject)

    11/13/24 4:16:57 PM ET
    $CYN
    EDP Services
    Technology